{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T07:48:03Z","timestamp":1769240883934,"version":"3.49.0"},"reference-count":0,"publisher":"International Scientific Information, Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Case Rep"],"DOI":"10.12659\/ajcr.916424","type":"journal-article","created":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T05:14:20Z","timestamp":1562390060000},"page":"965-970","source":"Crossref","is-referenced-by-count":8,"title":["Safety of an Abbreviated Transition Period When Switching From Intravenous Immunoglobulin to Eculizumab in Patients with Treatment-Refractory Myasthenia Gravis: A Case Series"],"prefix":"10.12659","volume":"20","author":[{"given":"Todd D.","family":"Levine","sequence":"first","affiliation":[{"name":"Department of Neurology, Phoenix Neurological Associates, Ltd., Phoenix, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4947","published-online":{"date-parts":[[2019,7,6]]},"container-title":["American Journal of Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.amjcaserep.com\/download\/index\/idArt\/916424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T05:14:20Z","timestamp":1562390060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.amjcaserep.com\/abstract\/index\/idArt\/916424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,6]]},"references-count":0,"alternative-id":["916424"],"URL":"https:\/\/doi.org\/10.12659\/ajcr.916424","relation":{},"ISSN":["1941-5923"],"issn-type":[{"value":"1941-5923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,6]]}}}